US supreme court's decision on the patent ineligibility of human genes BRCA1/BRCA2 as Products of Nature

Abstract

is a distinguished university professor at the University of Illinois at Chicago. In 1980 Dr. Chakrabarty's genetically modified Pseudomonas bacteria became the first genetically-engineered organism to gain a US patent, as a result of the Supreme Court decision in Diamond vs. Chakrabarty. He is the co-founder of two companies, CDG Therapeutics Inc. in Chicago and Amrita Therapeutics in India, that are developing protein/peptide anticancer agents from microbial sources.